News & Updates

Treatment with either high- or low-dose lebrikizumab reduces the rate of exacerbation in patients with uncontrolled asthma, according to the ACOUSTICS* trial presented at ATS 2022.

Patients with atherosclerotic cardiovascular disease (ASCVD) who quit smoking after acute coronary syndrome or revascularization have a comparable gain in event-free years as those who are on maximal pharmaceutical treatment, according to a study presented at the ESC Preventive Cardiology 2022 annual congress.

About one in eight patients with acute pulmonary embolism (aPE) has atrial fibrillation (AF), which contributes to increased short- and long-term mortality, a study has found.

Pharmaceutical workers who serve in healthcare settings are in danger of antineoplastic drug contamination not just inside the compounding room but also in adjacent rooms, reveals a study.

In two population-based Swedish cohorts of men and women with generally low tea consumption, tea intake was inversely associated with the incidence of abdominal aortic aneurysm (AAA).

Though auditory stimulation can effectively and remotely improve slow wave activity during sleep in older adults, its effects vary greatly between different individuals, according to a recent study.